- Home
- AMCI vs QNCX Comparison
AMCI vs QNCX Comparison
Compare AMCI & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMCI | QNCX |
|---|---|---|
| Founded | 2021 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 157.4M | 167.0M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | AMCI | QNCX |
|---|---|---|
| Price | $6.21 | $0.18 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 140.7K | ★ 142.3M |
| Earning Date | 01-01-0001 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $6,878,315.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $31.41 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.50 | $0.13 |
| 52 Week High | $42.00 | $4.55 |
Technical Indicators
Market Signals| Indicator | AMCI | QNCX |
|---|---|---|
| Relative Strength Index (RSI) | 48.97 | 27.90 |
| Support Level | $5.65 | $0.13 |
| Resistance Level | $6.72 | $0.98 |
| Average True Range (ATR) | 0.71 | 0.32 |
| MACD | 0.10 | -0.03 |
| Stochastic Oscillator | 51.20 | 1.72 |
Price Performance
Historical ComparisonAbout AMCI AMC Robotics Corporation Common Stock
AMC Robotics Corp is an artificial intelligence services company that develops robotic solutions designed to support operational efficiency across sectors such as logistics and manufacturing. The company develops robotics and automation technologies designed to improve logistics operations. Its robots use sensors and visual AI to support real-time decision-making, contributing to safer and more efficient warehouse operations. It builds autonomous robots for use in logistics and warehousing.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.